Ronald Kates
Impact in
- Cancer Research top 1%
- Protease and Inhibitor Mechanisms
- Breast Cancer Treatment Studies
- Oncology top 2%
- HER2/EGFR in Cancer Research
- Peptidase Inhibition and Analysis
Papers in
-
- Breast Cancer Treatment Studies 53
- Oncology 44
- HER2/EGFR in Cancer Research 17
- Cancer Treatment and Pharmacology 16
- Co-authors
- Nadia Harbeck (108 shared papers)Manfred Schmitt (24 shared papers)Marion Kiechle (13 shared papers)F. Jänicke (10 shared papers)Christoph Thomssen (15 shared papers)Helge Ritter (1 shared paper)Daniel Barsky (1 shared paper)Klaus Schulten (1 shared paper)
- Journals
- Journal of Clinical Oncology (35 papers)Annals of Oncology (11 papers)Cancer Research (10 papers)Breast Cancer Research and Treatment (7 papers)Journal of Plasma Physics (6 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Ronald Kates
174 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 166
- Cancer Research 1.2k
- Oncology 938
- Immunology and Allergy 181
- Hematology 152
- Genetics 140
Countries citing papers authored by Ronald Kates
This map shows the geographic impact of Ronald Kates's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald Kates with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald Kates more than expected).
Fields of papers citing papers by Ronald Kates
This network shows the impact of papers produced by Ronald Kates. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald Kates. The network helps show where Ronald Kates may publish in the future.
Co-authors
The 25 scholars most cited alongside Ronald Kates, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 187 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Neural computation and self-organizing maps : an introduction | 1992 | 368 |
| 2 | Enhanced benefit from adjuvant chemotherapy in breast cancer patients classified high-risk according to urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (n = 3424). | 2002 | 159 |
| 3 | 2004 | 125 | |
| 4 | 2006 | 105 | |
| 5 | 2002 | 104 | |
| 6 | 2007 | 101 | |
| 7 | Prognostic impact of proteolytic factors (urokinase-type plasminogen activator, plasminogen activator inhibitor 1, and cathepsins B, D, and L) in primary breast cancer reflects effects of adjuvant systemic therapy. | 2001 | 98 |
| 8 | 2005 | 90 | |
| 9 | 2008 | 85 | |
| 10 | 2003 | 84 | |
| 11 | 1999 | 78 | |
| 12 | 2019 | 78 | |
| 13 | 2004 | 77 | |
| 14 | 1999 | 77 | |
| 15 | 2013 | 73 | |
| 16 | 2009 | 62 | |
| 17 | 2002 | 57 | |
| 18 | 2021 | 51 | |
| 19 | 2007 | 46 | |
| 20 | 2000 | 44 |
About Ronald Kates
Ronald Kates is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Safety, Risk, Reliability and Quality and Astronomy and Astrophysics, having authored 187 papers that have together received 3.4k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (53 papers), Advanced Breast Cancer Therapies (31 papers), Traffic and Road Safety (20 papers), Traffic control and management (18 papers), HER2/EGFR in Cancer Research (17 papers), Human-Automation Interaction and Safety (16 papers), Cancer Treatment and Pharmacology (16 papers) and Autonomous Vehicle Technology and Safety (13 papers). The work is most often cited by research in Cancer Research (1.2k citations), Oncology (938 citations), Immunology and Allergy (181 citations), Hematology (152 citations) and Genetics (140 citations). Ronald Kates has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Nadia Harbeck, Manfred Schmitt, Marion Kiechle, F. Jänicke, Christoph Thomssen, Helge Ritter, Daniel Barsky, Klaus Schulten, Thomas Martinetz and Achim Krüger. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, Breast Cancer Research and Treatment and Journal of Plasma Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.